The bifunctional reagent 2-chloromethyl-6-cyanopyridine enables biocompatible, non-symmetric stapling of N-terminal and internal cysteines. Stapled peptides exhibit improved affinity, inhibition and stability and can be displayed on proteins.
A small molecular adapter enables site-specific peptide–protein conjugation via cysteine modification and cyanopyridine–aminothiol reactions, yielding complex branched or cyclic architectures for potential protein therapeutics.
A two-step, biocompatible strategy enables site-specific generation of branched and macrocyclic peptide–protein conjugates. Surface-exposed cysteines on proteins are modified by a small bifunctional reagent at near-physiological pH, followed by cyanopyridine–aminothiol click reactions to create branched or macrocyclic peptide architectures. This method offers design strategies for next-generation protein therapeutics.